These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 16648553)
1. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553 [TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis. Bagnato A; Rosanò L Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812 [TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137 [TBL] [Abstract][Full Text] [Related]
5. Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells. El Kharbili M; Robert C; Witkowski T; Danty-Berger E; Barbollat-Boutrand L; Masse I; Gadot N; de la Fouchardière A; McDonald PC; Dedhar S; Le Naour F; Degoul F; Berthier-Vergnes O Oncotarget; 2017 Mar; 8(10):17140-17155. PubMed ID: 28188308 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
7. Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Choi YP; Kim BG; Gao MQ; Kang S; Cho NH Biochem Biophys Res Commun; 2012 Oct; 427(3):642-8. PubMed ID: 23026047 [TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507 [TBL] [Abstract][Full Text] [Related]
10. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989 [TBL] [Abstract][Full Text] [Related]
11. Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. Rosanò L; Di Castro V; Spinella F; Tortora G; Nicotra MR; Natali PG; Bagnato A Cancer Res; 2007 Jul; 67(13):6351-9. PubMed ID: 17616694 [TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006 [TBL] [Abstract][Full Text] [Related]
13. Silencing of integrin-linked kinase suppresses in vivo tumorigenesis of human ovarian carcinoma cells. Li Q; Li C; Zhang YY; Chen W; Lv JL; Sun J; You QS Mol Med Rep; 2013 Mar; 7(3):1050-4. PubMed ID: 23340803 [TBL] [Abstract][Full Text] [Related]
14. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. Nho RS; Xia H; Kahm J; Kleidon J; Diebold D; Henke CA J Biol Chem; 2005 Jul; 280(28):26630-9. PubMed ID: 15905178 [TBL] [Abstract][Full Text] [Related]
15. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468 [TBL] [Abstract][Full Text] [Related]
18. Silencing of the integrin-linked kinase gene induces the apoptosis in ovarian carcinoma. Liu Q; Xiao L; Yuan D; Shi X; Li P J Recept Signal Transduct Res; 2012 Apr; 32(2):120-7. PubMed ID: 22384810 [TBL] [Abstract][Full Text] [Related]
19. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. Troussard AA; Mawji NM; Ong C; Mui A; St -Arnaud R; Dedhar S J Biol Chem; 2003 Jun; 278(25):22374-8. PubMed ID: 12686550 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cordes N Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]